Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenishaw Regulatory News (RSW)

Share Price Information for Renishaw (RSW)

Share Price is delayed by 15 minutes
Get Live Data
5,395.00    -60.00 (-1.10%)
Bid:
5,390.00
Ask:
5,400.00
Spread: 10.00 (0.186%)
Market Cap: £3.92b
RSW Live PriceLast checked at - London Stock Exchange

Intraday Renishaw Share Chart

Interim Management Statement

13 Oct 2011 11:05

RNS Number : 1203Q
Renishaw PLC
13 October 2011
 



 

Renishaw plc

Interim management statement

 

This statement has been prepared for the Group and relates to the three months ended 30th September 2011. It contains unaudited information that covers the first quarter and the period since.

 

Trading activity

Revenue for the three months to 30th September 2011 was £70.5m, an increase of 15.0% over the £61.3m for the first quarter of the previous year but below planned-for revenue. The previous year has been restated for the inclusion of Measurement Devices Limited from July 2010, which was initially accounted for as an associate company.

 

Geographically, Europe reported growth of 26% over the comparable period last year and the Americas a growth of 21%. The Far East, an area of significant growth last year, showed revenue for this quarter at a similar level to the corresponding quarter last year. By market sector, we have seen a slowdown in one of our product lines sold to the electronics industries.

 

Profit before tax for the first quarter amounted to £13.6m, compared with £15.1m last year.

 

The Group has increased its cost base compared with the comparable period last year, mainly by the addition of personnel to support its growing revenue and production demands, and investment in its research and development programmes. Headcount at the end of September 2011 was 2,745, an increase of 70 from the start of the financial year at 1st July 2011 and an increase of 538 over the 2,207 personnel at 30th September 2010.

 

Significant events and financial position

We are reviewing our healthcare business and have refocused part of the activities to a smaller number of projects, with some resources diverted to our metrology business.

 

The purchase of the Miskin premises, close to Cardiff in South Wales, was completed on 30th September 2011 and the Group also acquired premises for its Canadian and Italian subsidiaries. The aggregate cost of these acquisitions was £9.0m.

 

The Group continues to have a strong balance sheet with net cash balances at 30th September 2011 of £29.3m (30th June 2011 £34.6m).

 

I should like to thank our staff for their continuing efforts and support.

 

Outlook

It is still very early in the financial year and the Group traditionally has an order book of a little over one month's sales value. During the first quarter order intake has exceeded revenue and the Group has an order book of £31.9m at the end of September 2011.

 

Due to current uncertainties surrounding the global economy, the Board is closely monitoring the Group's costs and future recruitment strategy. Despite near-term challenges caused by the economic environment, we remain focused on positioning the Group for further long-term growth.

 

 

 

 

 

Sir David McMurtry CBE, RDI, FRS, FREng, CEng, FIMechE

Chairman and Chief Executive

 

13th October 2011

 

Renishaw plc

Registered office New Mills, Wotton-under-Edge, Gloucestershire, GL12 8JR

Registered number 1106260

Telephone number 01453 524524

Website www.renishaw.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSMJBMTMBMBBIB
Date   Source Headline
6th May 20267:00 amRNSTrading Statement
20th Apr 20267:00 amRNSTrading Statement
8th Apr 20267:00 amRNSBoard Changes
11th Feb 20267:00 amRNSHalf-year Financial Report
29th Jan 202612:00 pmRNSNotice of Half-year Results
28th Nov 202511:00 amRNSHolding(s) in Company
28th Nov 202511:00 amRNSHolding(s) in Company
27th Nov 20256:29 pmRNSHolding(s) in Company
27th Nov 20255:00 pmRNSDirector/PDMR Shareholding
26th Nov 20251:32 pmRNSResult of AGM
26th Nov 20258:30 amRNSShareholdings update
29th Oct 20254:00 pmRNSDirector/PDMR Shareholding
23rd Oct 20254:00 pmRNSDirector/PDMR Shareholding
23rd Oct 20257:00 amRNSTrading Statement
21st Oct 20253:02 pmRNSVoting Arrangement
21st Oct 20253:00 pmRNSHolding(s) in Company
21st Oct 20253:00 pmRNSHolding(s) in Company
3rd Oct 20257:00 amRNSAnnual Financial Report
24th Sep 20257:00 amRNSDirector/PDMR Shareholding
23rd Sep 20257:00 amRNSNew reporting segments for FY2026
18th Sep 20257:00 amRNSFinal Results
21st Aug 20257:00 amRNSBoard Change and Trading Update
13th Aug 20257:00 amRNSDirectorate Change
17th Jun 20257:00 amRNSCapital Markets Day
8th May 20257:00 amRNSTrading Statement
14th Apr 20259:49 amRNSDirector/PDMR Shareholding
13th Feb 20257:00 amRNSHalf-year Report
9th Dec 20242:02 pmRNSDeath of Sir David McMurtry
27th Nov 20242:44 pmRNSResult of AGM
29th Oct 20241:28 pmRNSDirector/PDMR Shareholding
24th Oct 20247:00 amRNSTrading Statement
27th Sep 20247:15 amRNSAnnual Financial Report
12th Sep 20247:00 amRNSFinal Results
29th Aug 20242:00 pmRNSNotice of Results
1st Jul 20247:00 amRNSDirectorate Change
13th Jun 20247:00 amRNSDirectorate Change
16th May 20242:25 pmRNSAGM Voting Results Update Statement
8th May 20247:00 amRNSTrading Statement
2nd Apr 20245:19 pmRNSStatement regarding Renishaw plc
6th Feb 20247:00 amRNSHalf-year Report
30th Jan 202410:30 amRNSChange of Adviser
23rd Jan 20249:00 amRNSNotice of Half-year Results
29th Nov 20232:47 pmRNSResult of AGM
26th Oct 20237:00 amRNSTrading Statement
13th Oct 20237:00 amRNSNotice of AGM
3rd Oct 20237:00 amRNSAnnual Financial Report
19th Sep 20237:00 amRNSFinal Results
13th Sep 20237:00 amRNSRevised date for publication of results
21st Aug 20233:00 pmRNSDirectorate Change
12th Jul 20232:30 pmRNSVoting Arrangement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.